Indication
Chemotherapy and Radiation Induced Nausea and Vomiting
1 clinical trial
2 products
Clinical trial
Phase II Randomized Study to Evaluate Efficacy, Patient Satisfaction, and Compliance of the Oral Combination of Rolapitant (Varubi®) Plus Ondansetron vs. Ondansetron Monotherapy in Malignant Glioma Patients Receiving Radiotherapy (RT) and Concomitant TemozolomideStatus: Completed, Estimated PCD: 2022-05-09
Product
RolapitantProduct
Ondansetron